Nordforsk - Personalised Paediatric Cancer

Nordforsk and the Norwegian Cancer Society have collaboratively published a call on personalised paediatric cancer. Deadline: October 3, 2018.

Nordic Clinical Trial Projects on Peadiatric Cancer Treatment

This call for projects aims to support Nordic researcher projects in cancer medicine or expansion of ongoing national projects into Nordic ones. A study at the Nordic level should lead to benefits beyond those of a single country study.

Projects of interest may focus on e.g. new drugs, new indications for existing drugs, new personalised applications of old treatments, and development of new medical devices. Evaluation of new treatments and new methods including new or revised surgical procedures will also be of relevance.

Eligibility:

Researchers and research groups at universities, hospitals and other research-performing institutions in the Nordic countries are eligible to apply for funding.

The Nordic countries are defined here as Denmark, Finland, Iceland, Norway, Sweden, Aaland Islands, Faroe Islands and Greenland.

The formal applicant must be an institution, organisation or other legal entity based in one of the Nordic countries.

The project consortium must involve partner institutions from at least three Nordic countries. Partner institutions from non-Nordic countries must fund their own participation.

Funding:

Total budget for this call: 38 million NOK
Available per project: 10 million NOK
Duration: 3-5 years

Link to call:

Nordic Clinical Trial Projects on Paediatric Cancer Treatment

Published May 16, 2018 1:46 PM - Last modified May 24, 2018 3:08 PM